Senores Pharmaceuticals Limited

Read Time:15 Second

Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2025, titled “Senores Pharmaceuticals, Inc. announces the approval and launch of Deferiprone Tablets USP, 500 mg & 1000 mg which will be marketed by Dr. Reddy s Laboratories Inc. in the US market”. |SUBJECT: Press Release

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Adani Enterprises Limited
Next post L&T Finance Limited